0001493152-20-023335.txt : 20201210 0001493152-20-023335.hdr.sgml : 20201210 20201210215531 ACCESSION NUMBER: 0001493152-20-023335 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201210 FILED AS OF DATE: 20201210 DATE AS OF CHANGE: 20201210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOKOLOW LEONARD J CENTRAL INDEX KEY: 0000923890 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39796 FILM NUMBER: 201382108 MAIL ADDRESS: STREET 1: 3010 NORTH MILITARY TRAIL STREET 2: STE 300 CITY: BOCA RATON STATE: FL ZIP: 33431 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vivos Therapeutics, Inc. CENTRAL INDEX KEY: 0001716166 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 813224056 STATE OF INCORPORATION: WY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 605 W.KNOX RD., STREET 2: SUITE 102 CITY: TEMPE STATE: AZ ZIP: 85284 BUSINESS PHONE: (480)567-9787 MAIL ADDRESS: STREET 1: 605 W.KNOX RD., STREET 2: SUITE 102 CITY: TEMPE STATE: AZ ZIP: 85284 FORMER COMPANY: FORMER CONFORMED NAME: Vivos BioTechnologies, Inc. DATE OF NAME CHANGE: 20170901 3 1 ownership.xml X0206 3 2020-12-10 0 0001716166 Vivos Therapeutics, Inc. VVOS 0000923890 SOKOLOW LEONARD J 9137 S. RIDGELINE BLVD, SUITE 135 HIGHLANDS RANCH CO 80129 1 0 0 0 Stock option (Right to buy) 7.50 2025-06-19 Common Stock 16667 D 16,667 stock options granted on June 19, 2020. One-half vested immediately and one-eighth vests quarterly every three months through June 19, 2021. Exhibit 24 /s/ SEAN McKENDRY as attorney-in-fact for Leonard Sokolow 2020-12-10 EX-24 2 ex24.htm

 

Exhibit 24

 

POWER OF ATTORNEY

 

Know all by these presents that the undersigned hereby constitutes and appoints each of Bradford Amman, Chief Financial Officer, and Sean McKendry, Controller, the undersigned’s true and lawful attorney-in-fact to:

 

(1) execute for and on behalf of the undersigned, in the undersigned’s capacity as an director of Vivos Therapeutics, Inc. (the “Company”), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder, and any other forms or reports the undersigned may be required to file in connection with the undersigned’s ownership, acquisition, or disposition of securities of the Company;

 

(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, or other form or report, and timely file such form or report with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

 

(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

 

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 10th day of December, 2020.

 

  /s/ Leonard Sokolow
  Signature
   
  Leonard Sokolow
  Print Name